What to check before you switch
Before moving volume, confirm the platform change does not disrupt the pharmacy layer underneath. List your highest-volume SKUs — semaglutide, tirzepatide, hormone and peptide lines — and verify the LegitScript-certified 503A partners assigned to your Fizy Health clinic can fill them. Both Refill and Fizy Health are ordering layers, not compounders; coverage is the first gate.
Second, review your Refill agreement for notice period, minimum commitment, Connect subscription terms, or termination language before you reduce transaction volume — these are clinic-specific and belong in your contract, not assumptions. Third, decide what operational data you carry over: patient demographics, common SIGs, and repeat-order SKUs. None of this requires an EMR migration; ordering portals live alongside your chart system. If you rely on Refill's outsourced provider network or Refill Connect patient billing, plan what happens to those workflows separately — Fizy Health does not replace outsourced MD coverage or a white-label storefront.